Ergot Alkaloids (片頭痛/Migraine)：医薬品市場予測及び分析（～2023）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 8
1.2 List of Figures 8
2 Introduction 9
2.1 Catalyst 9
2.2 Related Reports 9
2.3 Upcoming Related Reports 11
3 Disease Overview 12
3.1 Etiology and Pathophysiology 14
3.1.1 Etiology 14
3.1.2 Pathophysiology 15
3.1.3 Prognosis 16
3.2 Symptoms 16
3.2.1 Premonitory Phase 17
3.2.2 Aura Phase 17
3.2.3 Headache Phase 18
3.2.4 Postdrome Phase 18
4 Disease Management 19
4.1 Treatment Overview 19
4.1.1 Acute Migraine Treatment 22
4.1.2 Preventive Migraine Treatment 23
5 Competitive Assessment 24
5.1 Overview 24
5.2 Strategic Competitor Assessment 25
6 Ergot Alkaloids 27
6.1 Overview 27
6.2 Efficacy 29
6.3 Safety 31
6.4 SWOT Analysis 32
6.5 Forecast 32
7 Appendix 34
7.1 Bibliography 34
7.2 Abbreviations 37
7.3 Methodology 39
7.4 Forecasting Methodology 39
7.4.1 Diagnosed Migraine Patients 39
7.4.2 Percent Drug-treated Patients 39
7.4.3 General Pricing Assumptions 40
7.4.4 Individual Drug Assumptions 41
7.4.5 Generic Erosion 41
7.5 Physicians and Specialists Included in this Study 42
7.6 Survey of Prescribing Physicians 43
7.7 About the Authors 44
7.7.1 Author 44
7.7.2 Reviewer 44
7.7.3 Global Head of Healthcare 45
7.8 About GlobalData 46
7.9 Disclaimer 46